CJC-1295 DAC is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Binds GHRH receptors on pituitary somatotrophs to stimulate GH synthesis and secretion. The DAC module covalently binds to endogenous albumin, extending the half-life to 6-8 days while maintaining receptor bioavailability. This creates sustained, elevated GH levels rather than the pulsatile release seen with CJC-1295 no DAC.
How Does CJC-1295 DAC Work in the Body?
CJC-1295 DAC (CJC-1295 with Drug Affinity Complex) is a GHRH analog with extended half-life. Synthetic GHRH analog with four amino acid substitutions conjugated to a drug affinity complex that binds endogenous albumin.
Understanding its mechanism of action helps researchers design protocols and predict outcomes.
What Is the Primary Mechanism of CJC-1295 DAC?
Binds GHRH receptors on pituitary somatotrophs to stimulate GH synthesis and secretion. The DAC module covalently binds to endogenous albumin, extending the half-life to 6-8 days while maintaining receptor bioavailability. This creates sustained, elevated GH levels rather than the pulsatile release seen with CJC-1295 no DAC.
This mechanism operates at the cellular level and influences downstream pathways that produce the observable effects researchers study.
What Biological Pathways Does CJC-1295 DAC Affect?
As a GHRH analog with extended half-life, CJC-1295 DAC interacts with specific receptors and signaling cascades. These pathways are responsible for the compound's effects on sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass.
The multi-pathway activity is what gives CJC-1295 DAC its broad potential application range — each pathway contributes to different aspects of the overall effect profile.
How Quickly Does CJC-1295 DAC's Mechanism Take Effect?
With a half-life of 6-8 days, CJC-1295 DAC begins interacting with its target receptors within minutes of administration. However, the downstream biological effects take longer to manifest — typically days to weeks depending on the application.
Standard cycles run 12-16 weeks because that's the timeframe needed for the mechanism to produce measurable, cumulative results.
What Does the Research Say?
Single dose increases plasma GH 2-10 fold for 6+ days and IGF-1 0.5-3 fold for 9-11 days in humans. Multiple clinical trials demonstrated sustained dose-dependent GH/IGF-1 elevation. Reached Phase II before discontinuation.
The only GHRH analog with extended half-life allowing once-weekly dosing — but this convenience comes at the cost of sustained supraphysiological GH levels that bypass natural feedback, which is why most researchers prefer the no-DAC version.
Bottom Line on CJC-1295 DAC's Mechanism
CJC-1295 DAC works through ghrh analog with extended half-life activity to influence sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass. Its mechanism involves multiple pathways, which is why it shows potential across several research applications.
See our CJC-1295 DAC benefits guide for how this mechanism translates to practical outcomes.
Complete Guide
CJC-1295 DAC : Benefits, Dosage, Side Effects & Research
Related Reading
- CJC-1295 DAC Dosage Guide
- CJC-1295 DAC Benefits
- CJC-1295 DAC Side Effects
- CJC-1295 DAC Stacking Guide
- CJC-1295 DAC Cycle Guide
- CJC-1295 DAC Research
Calculate Your CJC-1295 DAC Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for CJC-1295 DAC.
Open Calculator →Research-Grade Sourcing
If you're going to research CJC-1295 DAC, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is CJC-1295 DAC?
CJC-1295 DAC (CJC-1295 with Drug Affinity Complex) is a GHRH analog with extended half-life. Synthetic GHRH analog with four amino acid substitutions conjugated to a drug affinity complex that binds endogenous albumin. It is researched for sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass.
What is the recommended CJC-1295 DAC dosage?
Common dosages: 1-2 mg per injection administered once or twice weekly via subcutaneous injection. Cycle length: 12-16 weeks. Half-life: 6-8 days. Use our peptide calculator for exact reconstitution math.
What are the side effects of CJC-1295 DAC?
Water retention, joint aches, fluid retention, mild headache. Sustained GH elevation may cause more pronounced side effects than pulsatile release versions. One subject death in Phase II trial was attributed to unrelated coronary artery disease.
Is CJC-1295 DAC safe?
CJC-1295 DAC has shown a preliminary safety profile in research. Not FDA-approved. Development discontinued post-Phase II. WADA banned. Available as research peptide. All research should follow appropriate safety protocols.